[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Medical Devices Pipeline Assessment, 2019

December 2019 | 157 pages | ID: PB3FC555BCDBEN
GlobalData

US$ 2,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Medical Devices Pipeline Assessment, 2019

SUMMARY

GlobalData's Medical Devices sector report, “Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Medical Devices Pipeline Assessment, 2019' provides an overview of Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

SCOPE
  • Extensive coverage of the Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
REASONS TO BUY

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
1.1 List of Tables
1.2 List of Figures

2 INTRODUCTION

2.1 Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters Overview

3 PRODUCTS UNDER DEVELOPMENT

3.1 Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Stage of Development
3.2 Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Territory
3.3 Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Regulatory Path
3.4 Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Estimated Approval Date
3.5 Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Ongoing Clinical Trials

4 PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) PERIPHERAL DRUG ELUTING BALLOONS (DEB) CATHETERS - PIPELINE PRODUCTS UNDER DEVELOPMENT BY COMPANIES

4.1 Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters Companies - Pipeline Products by Stage of Development
4.2 Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Stage of Development

5 PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) PERIPHERAL DRUG ELUTING BALLOONS (DEB) CATHETERS COMPANIES AND PRODUCT OVERVIEW

5.1 AnGes Inc Company Overview
  5.1.1 AnGes Inc Pipeline Products & Ongoing Clinical Trials Overview
5.2 AngioCure, Inc. Company Overview
  5.2.1 AngioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.3 Boston Scientific Corp Company Overview
  5.3.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
5.4 Cardionovum GmbH Company Overview
  5.4.1 Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.5 Concept Medical Inc Company Overview
  5.5.1 Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Contego Medical LLC Company Overview
  5.6.1 Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.7 eucatech AG Company Overview
  5.7.1 eucatech AG Pipeline Products & Ongoing Clinical Trials Overview
5.8 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
  5.8.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.9 Lutonix Inc Company Overview
  5.9.1 Lutonix Inc Pipeline Products & Ongoing Clinical Trials Overview
5.10 M.A. Med Alliance SA Company Overview
  5.10.1 M.A. Med Alliance SA Pipeline Products & Ongoing Clinical Trials Overview
5.11 Medtronic plc Company Overview
  5.11.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Micell Technologies Inc Company Overview
  5.12.1 Micell Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
5.13 Orchestra BioMed Inc Company Overview
  5.13.1 Orchestra BioMed Inc Pipeline Products & Ongoing Clinical Trials Overview
5.14 Pulsus Medical LLC (Inactive) Company Overview
  5.14.1 Pulsus Medical LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.15 QT Vascular Ltd Company Overview
  5.15.1 QT Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.16 QualiMed Innovative Medizinprodukte GmbH Company Overview
  5.16.1 QualiMed Innovative Medizinprodukte GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.17 SiL Vascular Ltd Company Overview
  5.17.1 SiL Vascular Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.18 Spectranetics Corp Company Overview
  5.18.1 Spectranetics Corp Pipeline Products & Ongoing Clinical Trials Overview
5.19 SurModics Inc Company Overview
  5.19.1 SurModics Inc Pipeline Products & Ongoing Clinical Trials Overview
5.20 Tailored Medical Devices Inc Company Overview
  5.20.1 Tailored Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview
5.21 TransMed7 LLC Company Overview
  5.21.1 TransMed7 LLC Pipeline Products & Ongoing Clinical Trials Overview
5.22 Vascular Nanotransfer Technologies Company Overview
  5.22.1 Vascular Nanotransfer Technologies Pipeline Products & Ongoing Clinical Trials Overview

6 PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) PERIPHERAL DRUG ELUTING BALLOONS (DEB) CATHETERS - RECENT DEVELOPMENTS

6.1 Nov 22, 2019: Medtronic receives FDA approval for IN.PACT AV DCB
6.2 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019
6.3 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report
6.4 Nov 12, 2019: Cardiovascular Systems announces Stephen Stenbeck joins Board of Directors
6.5 Nov 12, 2019: Cook Medical’s leadership updates in Asia-pacific reinforce focus on growth and physician relationships

7 APPENDIX

7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

LIST OF TABLES

Table 1: Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Stage of Development
Table 2: Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Territory
Table 3: Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Regulatory Path
Table 4: Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Estimated Approval Date
Table 5: Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Ongoing Clinical Trials
Table 6: Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters Companies - Pipeline Products by Stage of Development
Table 7: Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Stage of Development
Table 8: AnGes Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: NF-kB Decoy Oligo Coated PTA Balloon Catheter - Product Status
Table 10: NF-kB Decoy Oligo Coated PTA Balloon Catheter - Product Description
Table 11: AngioCure, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 12: AngioCure TOP-C Smart Balloon Catheter - Product Status
Table 13: AngioCure TOP-C Smart Balloon Catheter - Product Description
Table 14: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Ranger Drug-Coated Balloon - Product Status
Table 16: Ranger Drug-Coated Balloon - Product Description
Table 17: Boston Scientific Corp - Ongoing Clinical Trials Overview
Table 18: Ranger Drug-Coated Balloon - A Randomized Trial Comparing Drug-coated Balloon and Regular Balloon for Dialysis Access Stent Graft Restenosis
Table 19: Ranger Drug-Coated Balloon - Clinical Study of the Boston Scientific Paclitaxel-coated PTA (Percutaneous Transluminal Angioplasty) Balloon Catheter (Ranger and Ranger SL (OTW) DCB) in China
Table 20: Ranger Drug-Coated Balloon - JETStream AtheRectomy with Adjunctive Paclitaxel-coated Balloon Angioplasty Versus Balloon Angioplasty Followed by Paclitaxel-coated Balloon in Treating Complex Denovo Femoropopliteal Arterial Disease: JET-RANGER
Table 21: Ranger Drug-Coated Balloon - Prospective, Randomized, Multi-center Study for the Treatment of Subjects with Symptomatic Femoropopliteal Artery Disease with the Ranger Paclitaxel Coated PTA Balloon Catheter (Study Arm) Versus the IN.PACT Drug Eluting Balloon (Control Arm)
Table 22: Ranger Drug-Coated Balloon - Prospective, Randomized, Multicenter Clinical Study of the Hemoteq Ranger Paclitaxel-coated PTA Balloon Catheter (Ranger DCB) in Comparison to Uncoated PTA Balloons in Femoropopliteal Lesions
Table 23: Ranger Drug-Coated Balloon - RANGER II SFA: A 3:1 Randomized Trial Comparing the Boston Scientific RANGER Paclitaxel Coated Balloon Versus Standard Balloon Angioplasty for the Treatment of Superficial Femoral Arteries (SFA) and Proximal Popliteal Arteries (PPA)
Table 24: Cardionovum GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 25: APERTO OTW - Product Status
Table 26: APERTO OTW - Product Description
Table 27: Cardionovum GmbH - Ongoing Clinical Trials Overview
Table 28: APERTO OTW - A Randomized Trial of Aperto Paclitaxel Eluting Dilatation Catheter Compared to POBA in Dialysis Fistula
Table 29: Concept Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 30: MagicTouch PTA Balloon Catheter - Product Status
Table 31: MagicTouch PTA Balloon Catheter - Product Description
Table 32: Concept Medical Inc - Ongoing Clinical Trials Overview
Table 33: MagicTouch PTA Balloon Catheter - A Pilot Study to Evaluate the Safety and Efficacy of MagicTouch PTA Sirolimus Coated Balloon for the Treatment of Below-the-Knee (BTK) Lesions
Table 34: Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Tibial Artery Drug Eluting Balloon - Product Status
Table 36: Tibial Artery Drug Eluting Balloon - Product Description
Table 37: eucatech AG Pipeline Products & Ongoing Clinical Trials Overview
Table 38: Support - Product Status
Table 39: Support - Product Description
Table 40: Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 41: FemFlow Drug-Eluting Peripheral Balloon Catheter (DEB) - Product Status
Table 42: FemFlow Drug-Eluting Peripheral Balloon Catheter (DEB) - Product Description
Table 43: Lifetech Scientific (Shenzhen) Co Ltd - Ongoing Clinical Trials Overview
Table 44: FemFlow Drug-Eluting Peripheral Balloon Catheter (DEB) - Safety and Efficacy Study of FemFlow Drug-eluting Peripheral Balloon Catheter for Lesions with Femoral-popliteal Artery Stenosis or Occlusion: A Prospective, Multi-center, Objective Performance Criteria Clinical Trial
Table 45: Lutonix Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 46: Lutonix 014 Drug Coated Balloon PTA Catheter - Product Status
Table 47: Lutonix 014 Drug Coated Balloon PTA Catheter - Product Description
Table 48: Lutonix 018 Drug Coated Balloon PTA Catheter - Product Status
Table 49: Lutonix 018 Drug Coated Balloon PTA Catheter - Product Description
Table 50: Lutonix Inc - Ongoing Clinical Trials Overview
Table 51: Lutonix 014 Drug Coated Balloon PTA Catheter - A Prospective, Multicenter, Single Arm Real-world Registry Investigating the Clinical Use and Safety of the Lutonix Drug Coated Balloon Percutaneous Transluminal Angioplasty (PTA) Catheter for Treatment of Below-the-Knee (BTK) Arteries
Table 52: Lutonix 014 Drug Coated Balloon PTA Catheter - A Prospective, Multicenter, Single Blind, Randomized, Controlled Trial Comparing the Lutonix Drug Coated Balloon Versus Standard Balloon Angioplasty for Treatment of Below-the-knee (BTK) Arteries: Lutonix BTK Trial
Table 53: Lutonix 014 Drug Coated Balloon PTA Catheter - Tack Optimized Balloon Angioplasty Study for Superficial Femoral and Proximal Popliteal Arteries Using the Tack Endovascular System
Table 54: Lutonix 018 Drug Coated Balloon PTA Catheter - Drug Eluting Balloon for Early Fistula Failure Trial
Table 55: M.A. Med Alliance SA Pipeline Products & Ongoing Clinical Trials Overview
Table 56: SELUTION Sirolimus Coated Balloon - Product Status
Table 57: SELUTION Sirolimus Coated Balloon - Product Description
Table 58: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview
Table 59: IN.PACT Admiral DEB - BTK - Product Status
Table 60: IN.PACT Admiral DEB - BTK - Product Description

LIST OF FIGURES

Figure 1: Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Stage of Development
Figure 2: Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Territory
Figure 3: Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Regulatory Path
Figure 4: Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Pipeline Products by Estimated Approval Date
Figure 5: Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) Catheters - Ongoing Clinical Trials

COMPANIES MENTIONED

AnGes Inc
AngioCure, Inc.
Boston Scientific Corp
Cardionovum GmbH
Concept Medical Inc
Contego Medical LLC
eucatech AG
Lifetech Scientific (Shenzhen) Co Ltd
Lutonix Inc
M.A. Med Alliance SA
Medtronic plc
Micell Technologies Inc
Orchestra BioMed Inc
QT Vascular Ltd
QualiMed Innovative Medizinprodukte GmbH
SiL Vascular Ltd
Spectranetics Corp
SurModics Inc
Tailored Medical Devices Inc
TransMed7 LLC
Vascular Nanotransfer Technologies


More Publications